Advanced search×

Involvement of cricoarytenoid joints in rheumatoid arthritis.

Paola P Feraco, Alberto A Bazzocchi, Silvia S Righi, Giuseppe G Zampogna, Gabriella G Savastio, and Eugenio E Salizzoni

J Clin Rheumatol 15(5):264 (2009) PMID 19654493

DOI: 10.1097/RHU.0b013e3181b2a965
Version: za2963e q8zab q8zb7 q8zc1 q8zd8 q8ze2 q8zf0 q8zgc
Buy PDF

Similar articles you may find interesting…

  1. Differentially expressed epigenome modifiers, including Aurora kinase A and B, in immune cells of rheumatoid arthritis.
    Tibor T Glant, Timea Besenyei, and Tibor A Rauch

    Arthritis Rheum (2013) PMID 23653330

    Arthritis development is accompanied the changes in the expression of a number of epigenome-modifying enzymes. Drug-induced downregulation of the Aurora kinases, among other targets, seems to be sufficient to treat experimental arthritis. Development of new therapeutics that target the Aurora kinase...
    Buy PDF
  2. Host Modulation in Rheumatoid Arthritis Patients with TNF Blockers Significantly Decreases Biochemical Parameters in Periodontitis.
    Kemal Ustün, Kamile Erciyas, and Ahmet Mesut Onat

    Inflammation (2013) PMID 23649513

    These results suggest that TNF blockers may significantly modify host response in terms of biochemical parameters of the periodontium and may mask significant associations such as those reported between periodontitis and rheumatoid arthritis....
    Buy PDF
  3. Deletion of the receptor tyrosine kinase Tyro3 inhibits synovial hyperplasia and bone damage in arthritis.
    Gisela Ruiz-Heiland, Yi Zhao, and Georg Schett

    Ann Rheum Dis (2013) PMID 23632195

    These findings indicate that Tyro3 is a critical signal for synovial hyperplasia, osteoclast differentiation and bone erosion during arthritis. GAS6 and Tyro3 therefore constitute therapeutic targets to inhibit synovial hyperplasia and associated bone erosion....
    Buy PDF